Amaroswerin

CAS : 21233-18-1

Ref. 3D-WAA23318

Informations sur le produit

• Nom: Amaroswerin
• Synonymes: [1,1′-Biphenyl]-2-carboxylic acid, 3,3′,5-trihydroxy-, 2′-ester with 5-ethenyl-6-(β-D-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-1H,3H-pyrano[3,4-c]pyran-1-one, [4aR-(4aα,5β,6α)]-, 1H,3H-Pyrano[3,4-c]pyran-1-one, 5-ethenyl-4,4a,5,6-tetrahydro-4a-hydroxy-6-[[2-O-[(3,3′,5-trihydroxy[1,1′-biphenyl]-2-yl)carbonyl]-β-D-glucopyranosyl]oxy]-, (4aR,5R,6S)-, 1H,3H-Pyrano[3,4-c]pyran, [1,1′-biphenyl]-2-carboxylic acid deriv., (4aR,5R,6S)-5-Ethenyl-4,4a,5,6-tetrahydro-4a-hydroxy-6-[[2-O-[(3,3′,5-trihydroxy[1,1′-biphenyl]-2-yl)carbonyl]-β-D-glucopyranosyl]oxy]-1H,3H-pyrano[3,4-c]pyran-1-one

Description

Amaroswerin is an analog of a medicinal plant compound that has been shown to have potent anticancer properties. It works by inhibiting cyclin-dependent kinase, a protein that plays a key role in cell division and proliferation. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Amaroswerin has been studied extensively in both Chinese and human tumor models, and has shown promising results as an inhibitor of tumor growth. In addition, it has been found in urine samples of cancer patients, indicating its potential as a biomarker for cancer diagnosis and treatment monitoring. Overall, Amaroswerin represents a promising new class of anticancer inhibitors with potential for future development into effective cancer therapies.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 602.5 g/mol
• Formule: C₂₉H₃₀O₁₄
• Degré de pureté: Min. 95%